HomeXRTX • NASDAQ
add
XORTX Therapeutics Inc
Previous close
$0.91
Day range
$0.90 - $1.00
Year range
$0.85 - $7.00
Market cap
4.96M CAD
Avg Volume
196.10K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 607.32K | -45.31% |
Net income | -587.01K | 55.98% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -597.24K | 45.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.30M | -54.61% |
Total assets | 3.85M | -42.01% |
Total liabilities | 1.72M | 210.02% |
Total equity | 2.13M | — |
Shares outstanding | 3.22M | — |
Price to book | 1.25 | — |
Return on assets | -35.11% | — |
Return on capital | -60.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -587.01K | 55.98% |
Cash from operations | -751.85K | 29.78% |
Cash from investing | -23.18K | -217.59% |
Cash from financing | -22.24K | -33.38% |
Net change in cash | -777.72K | 28.97% |
Free cash flow | -304.05K | 30.74% |
About
Founded
2011
Headquarters
Website
Employees
3
